Quote:

---

I’ll take an r/s over another failed trial PR because at least we’ll have better leadership.

---

An r/s would crush the pps to dust. The SP dropping after calls is in the pennies. Give me a dozen more CCs over an r/s.

You have said, to your credit, many times Cytodyn would ace CD16 with the knowledge they have now. So why are you advocating for a new CEO and r/s when we could so "easily" slide over the finish line?

I've giving NP a little more slack because whether you like it or not he *has* advanced Leronlimab in multiple overseas territories. If he cannot turn that into revenue, then yes let's revisit his value or lack thereof as CEO.

For now, you're quest to oust NP is clearly personal and far beyond any business blunders he has made. Are you gunning for the job yourself, is that what this years long saga of your NP hatred has been about? Your blame for all the missteps is myopic. NP is fighting some powerful forces in the market. He can be blamed for a lot, but not all.